Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry.
Gillat
Adi
A
Heller Ehrman White &McAuliffe, Washington, D.C., USA.
D004059:Diffusion of Innovation; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006273:Health Facility Merger / Q000331:legislation & jurisprudence; D006297:Health Services Accessibility; D006801:Humans; D008004:Licensure / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D014481:United States